Table II.
Parameter | Time P value |
Treatment P value |
Interaction P value |
---|---|---|---|
FT3 | .56 | .01 | .82 |
FT4 | .50 | .25 | .67 |
FT3/FT4 | .17 | .001 | .87 |
TSH | .42 | .008 | .36 |
Plasma sitostanol | .002 | <.0001 | .02 |
Plasma sitostanol/TC | .005 | .31 | <.0001 |
RBC sitostanol | <.0001 | .001 | .06 |
RBC sitostanol/TC | .07 | .03 | .001 |
Plasma cholestanol | <.0001 | <.0001 | .003 |
Plasma cholestanol/TC | .005 | .03 | .02 |
RBC cholestanol | .30 | <.0001 | .08 |
RBC cholestanol/TC | .009 | .006 | <.0001 |
Plasma TC | <.0001 | <.0001 | .004 |
RBC TC | .01 | .006 | .002 |
Plasma lathosterol | .24 | .04 | .01 |
Plasma lathosterol/TC | .13 | <.0001 | .004 |
RBC lathosterol | <.0001 | <.0001 | .26 |
RBC lathosterol/TC | <.0001 | <.0001 | .43 |
Serum 7α-H-C4 | .49 | .32 | .31 |
Serum 7α-H-C4/TC | .45 | .63 | .26 |